Review Articles
Vol. 2 No. 1 (2018)
https://doi.org/10.4081/tmr.6803

Anaplastic lymphoma tyrosine kinase oncogene in human cancer: gene aberrations, methods of detection and therapeutic potential

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 17 May 2017
Published: 27 November 2017
1743
Views
730
Downloads
Anaplastic lymphoma kinase, Target therapy, Non small cell lung cancer
Anaplastic Lymphoma Kinase(term1), Non Small Cell Lung Cancer(term 2), Target Therapy (term3)

Authors

Rosalaura Sabetta
Pathology Unit, Second University of Naples, Naples, Italy.
Monica Gargiulo
Pathology Unit, Second University of Naples, Naples, Italy.
Marina Accardo
Pathology Unit, Second University of Naples, Naples, Italy.
Federica Zito Marino
Pathology Unit, Second University of Naples, Naples, Italy.
Renato Franco
renato.franco@unicampania.it
Pathology Unit, Second University of Naples, Naples, Italy.
Anaplastic lymphoma tyrosine kinase (ALK) gene could be an attractive oncotarget in human cancers, since it is involved in several genetic alterations resulting in an aberrant activity of the receptor. To date, ALK-rearrangement represents a molecular target for the treatment of ALK-rearranged Non Small Cell Lung Cancer patients, who are highly sensitive to crizotinib, a specific inhibitor. ALK-rearranged patients treated with crizotinib show relevant clinical implications, however several different resistance mechanisms have been identified. Here we review various critical issues related to ALK-targeting therapy, including ALK gene aberrations, methods of detection, mechanism of acquired resistance and second-generation ALK inhibitors.

Downloads

Download data is not yet available.

How to Cite



Anaplastic lymphoma tyrosine kinase oncogene in human cancer: gene aberrations, methods of detection and therapeutic potential. (2017). Translational Medicine Reports, 2(1). https://doi.org/10.4081/tmr.6803

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.